Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Editorial Volume 6 Issue 9

The Interpolated Wen-Keratocystoma - Salivary Gland

Anubha Bajaj*

Department of Histopathology, Panjab University/A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A.B. Diagnostics, India.

Received: July 24, 2023; Published: August 01, 2023

Keratocystoma emerges as an exceptionally discerned, benign tumour incriminating salivary glands. Initially scripted by Seifert as choristoma and subsequently by Nagao, tumefaction is configured of squamous epithelial cell layered multi-cystic spaces intermingled with focal areas of solid squamous epithelial cell nests.

References

  1. Cunha JL., et al. “Salivary gland tumors: A 13-year clinicopathologic retrospective study in a Brazilian northeast population”. Journal of Clinical and Experimental Dentistry 2 (2023): e88-e95.
  2. Nishida H., et al. “Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers”. Cancers (Basel)4 (2023): 1236.
  3. Anparasan A., et al. “Parotid gland keratocystoma: a rare diagnosis of a neck lump”. BMJ Case Report12 (2022): e252039.
  4. Saraniti C., et al. “Cystic lesion in parotid region: an unexpected diagnosis”. BMJ Case Report8 (2022): e249528.
  5. Skálová A., et al. “Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands”. Head and Neck Pathology1 (2022): 40-53.
  6. Stewart KE., et al. “Benign parotid mass and facial palsy: systematic review”. Annals of The Royal College of Surgeons of England 1 (2021): 47-52.
  7. Komatsu H., et al. “Keratocystoma of the parotid gland”. Auris Nasus Larynx3 (2020): 481-484.
  8. Image 1 Courtesy: Science direct.
  9. Image 2 Courtesy: Nature.com.

Citation

Citation: Anubha Bajaj. “The Interpolated Wen-Keratocystoma - Salivary Gland". Acta Scientific Gastrointestinal Disorders 6.9 (2023): 01-03.

Copyright

Copyright: © 2023 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


Contact US